Sanitas AB
Received report on the implementation of mandatory non-competitive tender offer
Sanitas AB 20.09.2011 15:13 --------------------------------------------------------------------------- Kaunas, Lithuania, 2011-09-20 15:13 CEST (GLOBE NEWSWIRE) -- On 20 September 2011 AB SANITAS received a report from its shareholder Valeant Pharmaceuticals International, Inc. on the implementation of the mandatory non-competitive tender offer. Through the implementation period of the tender offer Valeant Pharmaceuticals International, Inc. bought-up 1,968,631 ordinary registered shares of AB SANITAS with nominal value of LTL 1 each (ISIN code LT0000106171), which represent 6.33 percent of voting rights at the general meeting of shareholders of the company. Enclosed: The statement on the implementation of the tender offer. This announcement is also available on AB SANITAS' website: www.sanitasgroup.com. A person authorized to provide additional information: Mr. Saulius Jurgelenas, Chief Executive Officer of AB SANITAS, phone number +370 686 67779. Lawyer Dovilė Morkytė +370 615 15163 News Source: NASDAQ OMX 20.09.2011 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Sanitas AB Lithuania Phone: Fax: E-mail: Internet: ISIN: LT0000106171 WKN: End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden